Hints and tips:
..., UK, US: S&P Global/HCOB services purchasing managers’ index (PMI) figures Indonesia: Q4 GDP figures Mexico: Constitution Day holiday....
...Now, about 1,000 scientists, engineers and technicians at PMI’s vast R&D facility in Neuchâtel, work solely on development of reduced-risk products....
...“But if I felt that R&D was lacking, I wouldn’t have taken that bet. I’m not suicidal.” Our mains long since finished, lunch extends into a third hour and we each order an espresso....
...The pharmaceutical company had poured hundreds of millions of dollars into research and development for vaccines — and yet, at 33 years old, was approaching middle age without a single approved shot....
...The three joined from the S&P 400 benchmark of midsized companies and will switch places with tax software group H&R Block, Coty, a beauty company, and Kohls, a department store, which are dropping to the...
...Third, Japan Inc will be a serious player in renewable energy (finally). Exporting high-efficiency coal-power projects has been one of the pillars of the government’s infrastructure export strategy....
...S.O.L.A.R. You know, when someone or something is solar, and has a sunny or happy energy?”...
...Sanofi plans to sell down most of its 20.6 per cent stake in US biotech Regeneron as part of chief executive Paul Hudson’s promised overhaul of the French pharmaceutical maker....
...The boom in debt issuance by corporate America has been good to S&P Global, the largest credit rating agency. Its shares have jumped a fifth in 2020, far outpacing its namesake S&P 500 index....
...Allergan has a strong long-term outlook across its four key therapeutics areas and a highly promising R&D pipeline.”...
...Toys R Us plans to shut 180 stores across the US in the coming months, slashing about a fifth of its physical presence in its home market as it looks to claw out of bankruptcy....
...Emma Walmsley, who took over from Sir Andrew Witty as chief executive in April, worked for L’Oréal for 17 years before joining the pharmaceuticals company in 2010. —————————- For its 130 senior executives...
...In Canada, attention was focused on Concordia International, a pharmaceuticals company....
...Letter in response to this editorial: S-I-M-P-L-E R-E-A-L-L-Y / From Jonathan P Kahn...
...This has left the company’s share price almost unchanged over the period while the S&P pharmaceuticals index has doubled....
...The S&P pharmaceuticals index has almost doubled since the beginning of 2013. In the same period, shares in GSK are up barely more than 1 per cent....
...Shares of L Brands rose more than 4 per cent to $89.28 after the company behind Victoria’s Secret and La Senza reported August sales that topped analysts’ forecasts....
...Investors appear confident: S&P’s pharmaceuticals index has risen by almost a quarter in the past year. Amid all this optimism, however, there is little sense of triumph among pharma executives....
...L Brands shares advanced 2 per cent to $96.53, after the retailer said same-store sales, a key industry metric, had climbed 9 per cent in September from a year ago....
...This optimism is reflected in the 40 per cent jump in the S&P pharmaceuticals index over the past year, compared with a 7 per cent rise in the broader S&P 500....
...But they are joined by well-known US companies such as Weight Watchers, Toys R Us, Sears, and Advanced Micro Devices, a chipmaker....
...Bioprinting is also being looked at by pharmaceuticals companies as a way of speeding up and lowering the cost of drug development and testing....
...“My gut reaction is that biotech valuations are always too high,” says Amit Roy, a pharmaceuticals analyst at the independent Foveal research group....
...A dozen of its S&P 500 peers have climbed more than 40 per cent....
...previously run as a joint venture with L’Oréal....
International Edition